The NGS Oncology DxBook, piloted in 2022 and revamped in 2023, captures in-depth information regarding in-house and send-out oncology NGS panel testing behaviors.
The NGS DxBook provides comprehensive demographic, infrastructure, and panel information for both labs performing in-house NGS testing and institutions outsourcing their testing to centralized providers.
For labs that perform in-house testing, you will receive information about their current infrastructure, plans to adopt new infrastructure within the next 12 months, and adoption criteria. Panel details include tissue usage liquid vs. tissue/organ-wise splits, exact workflow components (automation, sequencers, kits, bioinformatics), reimbursement, and costs.
For institutions that outsource their testing, you will receive information on the labs they currently send their tests to, testing volumes, reasons for not performing in-house testing, and plans for in-sourcing NGS testing, including their adoption criteria.
The chart illustrates the annual volume of NGS testing versus hospital bed size, including reference labs (0 beds). A key insight is that institutions with an annual NGS testing volume above 1,250 samples (or roughly 25 samples per week) are more likely to adopt in-house NGS capabilities.
This can provide actionable strategies for companies. For example, manufacturers may target institutions in the NGS DxBook with annual send-out NGS volumes around 1,250, offering tailored solutions to support their transition and optimize in-house testing. While, centralized providers could identify and monitor accounts nearing this volume threshold to mitigate the risk of losing business to in-house testing, while also providing value-add services that complement the NGS portfolio these labs plan to in-house to retain these customers.
By understanding these thresholds and market dynamics, companies across the NGS industry can better strategize their market approach and improve their engagement with potential and existing clients. Access to longitudinal data allows you to see how these trends have shifted YoY, providing deeper insights into market dynamics and enabling more strategic decision-making.
